$FOXO
FOXO TECHNOLOGIES INC. Stock $foxo

$foxo Overview Financials Valuation SEC Filings Company Website

2022 Q4 Form 10-Q Financial Statement

#000121390022074296 Filed on November 21, 2022

Income Statement

Concept	2022 Q4	2022 Q3	2021 Q4
Revenue	$420.0K	$14.00K	$0.00
YoY Change
Cost Of Revenue	$340.0K	$14.00K
YoY Change		-54.84%
Gross Profit	$70.00K	$0.00
YoY Change		-100.0%
Gross Profit Margin	16.67%	0.0%
Selling, General & Admin	$11.60M	$8.269M	$523.9K
YoY Change	2114.08%	2183.88%	1209.8%
% of Gross Profit	16571.43%
Research & Development	$890.0K	$558.0K	$560.0K
YoY Change	58.93%	-66.49%
% of Gross Profit	1271.43%
Depreciation & Amortization	$1.330M	$70.00K	$30.00K
YoY Change	4333.33%	250.0%
% of Gross Profit	1900.0%
Operating Expenses	$22.58M	$8.827M	$523.9K
YoY Change	4209.82%	2337.99%	1209.8%
Operating Profit	-$22.51M	-$8.813M
YoY Change		102.37%
Interest Expense	-$25.52M	$424.0K	$1.665M
YoY Change	-1632.87%	-41.85%	-360.13%
% of Operating Profit
Other Income/Expense, Net	-$60.00K	-$779.0K	-$210.0K
YoY Change	-71.43%	38850.0%
Pretax Income	-$48.07M	-$41.03M	$1.141M
YoY Change	-4313.23%	-11277.53%	-270.29%
Income Tax	$0.00	$0.00	$0.00
% Of Pretax Income			0.0%
Net Earnings	-$48.07M	-$41.03M	$1.141M
YoY Change	-4313.23%	-11277.53%	-270.29%
Net Earnings / Revenue	-11445.24%	-293042.86%
Basic Earnings Per Share
Diluted Earnings Per Share	-$1.75	-$0.34	$44.24K
COMMON SHARES
Basic Shares Outstanding	31.19M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2022 Q4	2022 Q3	2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$5.520M	$10.45M	$638.2K
YoY Change	764.89%	935.14%	-54.41%
Cash & Equivalents	$5.515M	$10.45M	$638.2K
Short-Term Investments
Other Short-Term Assets	$114.0K	$20.00K	$234.3K
YoY Change	-51.34%	-91.54%	-53.15%
Inventory	$1.313M	$2.057M	$295.0K
Prepaid Expenses	$2.686M	$511.0K	$234.3K
Receivables
Other Receivables
Total Short-Term Assets	$12.30M	$17.80M	$872.5K
YoY Change	1310.22%	1328.54%	-54.08%
LONG-TERM ASSETS
Property, Plant & Equipment		$136.0K	$187.0K
YoY Change
Goodwill
YoY Change
Intangibles	$2.043M	$2.071M	$191.0K
YoY Change	969.63%
Long-Term Investments		$100.0K	$201.3M
YoY Change		-99.95%	-0.01%
Other Assets	$21.06M	$23.46M
YoY Change
Total Long-Term Assets	$23.10M	$53.69M	$201.3M
YoY Change	-88.52%	-73.33%	0.04%
TOTAL ASSETS
Total Short-Term Assets	$12.30M	$17.80M	$872.5K
Total Long-Term Assets	$23.10M	$53.69M	$201.3M
Total Assets	$35.41M	$71.49M	$202.2M
YoY Change	-82.48%	-64.7%	-0.47%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.466M	$2.706M	$309.5K
YoY Change	1019.93%	1600.82%
Accrued Expenses	$1.045M	$500.0K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$1.410M
YoY Change
Total Short-Term Liabilities	$6.913M	$33.01M	$314.5K
YoY Change	2098.21%	20017.0%
LONG-TERM LIABILITIES
Long-Term Debt	$1.730M	$2.920M	$0.00
YoY Change
Other Long-Term Liabilities	$20.06M	$21.08M	$12.13M
YoY Change	65.34%	52.83%	-32.97%
Total Long-Term Liabilities	$21.79M	$24.00M	$12.13M
YoY Change	79.6%	74.0%	-32.97%
TOTAL LIABILITIES
Total Short-Term Liabilities	$6.913M	$33.01M	$314.5K
Total Long-Term Liabilities	$21.79M	$24.00M	$12.13M
Total Liabilities	$28.70M	$55.72M	$12.45M
YoY Change	130.58%	299.23%	-31.23%
SHAREHOLDERS EQUITY
Retained Earnings	-$147.2M	-$128.9M	-$11.58M
YoY Change	1171.97%
Common Stock	$3.000K	$3.000K	$63.00
YoY Change	4661.9%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares	2.141M shares
Shareholders Equity	$6.708M	$15.77M	-$11.57M
YoY Change
Total Liabilities & Shareholders Equity	$35.41M	$71.49M	$202.2M
YoY Change	-82.48%	-64.7%	-0.47%

Cashflow Statement

Concept	2022 Q4	2022 Q3	2021 Q4
OPERATING ACTIVITIES
Net Income	-$48.07M	-$41.03M	$1.141M
YoY Change	-4313.23%	-11277.53%	-270.29%
Depreciation, Depletion And Amortization	$1.330M	$70.00K	$30.00K
YoY Change	4333.33%	250.0%
Cash From Operating Activities	-$5.300M	-$4.270M	-$371.3K
YoY Change	1327.42%	2661.43%	-22.65%
INVESTING ACTIVITIES
Capital Expenditures	$140.0K	$470.0K	$160.0K
YoY Change	-12.5%	840.0%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00	$0.00
YoY Change			-100.0%
Cash From Investing Activities	-$140.0K	-$470.0K	$0.00
YoY Change			-100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	500.0K	-3.300M	0.000
YoY Change			-100.0%
NET CHANGE
Cash From Operating Activities	-5.300M	-4.270M	-371.3K
Cash From Investing Activities	-140.0K	-470.0K	0.000
Cash From Financing Activities	500.0K	-3.300M	0.000
Net Change In Cash	-4.940M	-8.040M	-371.3K
YoY Change	1230.46%	5099.51%	-126.15%
FREE CASH FLOW
Cash From Operating Activities	-$5.300M	-$4.270M	-$371.3K
Capital Expenditures	$140.0K	$470.0K	$160.0K
Free Cash Flow	-$5.440M	-$4.740M	-$531.3K
YoY Change	923.9%	2216.38%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-09-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-39783
	dei	Entity Registrant Name EntityRegistrantName	FOXO TECHNOLOGIES INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	85-1050265
	dei	Entity Address Address Line1 EntityAddressAddressLine1	729 N. Washington Ave
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 600
	dei	Entity Address City Or Town EntityAddressCityOrTown	Minneapolis
	dei	Entity Address State Or Province EntityAddressStateOrProvince	MN
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	55401
	dei	City Area Code CityAreaCode	(612)
	dei	Local Phone Number LocalPhoneNumber	562-9447
	dei	Security12b Title Security12bTitle	Class A Common Stock, par value $0.0001
	dei	Trading Symbol TradingSymbol	FOXO
	dei	Security Exchange Name SecurityExchangeName	NYSE
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	31187069	shares
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	10454000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6856000	usd
CY2022Q3	us-gaap	Inventory Net InventoryNet	2057000	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	295000	usd
CY2022Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	511000	usd
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	444000	usd
CY2022Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4758000	usd
CY2022Q3	us-gaap	Other Assets Current OtherAssetsCurrent	20000	usd
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	23000	usd
CY2022Q3	us-gaap	Assets Current AssetsCurrent	17800000	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	7618000	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	136000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	187000	usd
CY2022Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2071000	usd
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	191000	usd
CY2022Q3	us-gaap	Investments Investments	100000	usd
CY2021Q4	us-gaap	Investments Investments	100000	usd
CY2022Q3	us-gaap	Reinsurance Recoverables ReinsuranceRecoverables	18754000	usd
CY2021Q4	us-gaap	Reinsurance Recoverables ReinsuranceRecoverables	19463000	usd
CY2022Q3	us-gaap	Property Plant And Equipment Other Net PropertyPlantAndEquipmentOtherNet	4709000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Other Net PropertyPlantAndEquipmentOtherNet	2745000	usd
CY2022Q3	foxo	Forward Purchase Collateral ForwardPurchaseCollateral	27919000	usd
CY2022Q3	us-gaap	Assets Assets	71489000	usd
CY2021Q4	us-gaap	Assets Assets	30304000	usd
CY2022Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	2706000	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	3456000	usd
CY2022Q3	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	500000	usd
CY2022Q3	us-gaap	Deposit Liability Current DepositLiabilityCurrent	384000	usd
CY2022Q3	foxo	Parallel Run Advance ParallelRunAdvance	256000	usd
CY2022Q3	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	504000	usd
CY2021Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	402000	usd
CY2022Q3	foxo	Forward Purchase Put Derivative ForwardPurchasePutDerivative	1284000	usd
CY2022Q3	foxo	Forward Purchase Collateral Derivative ForwardPurchaseCollateralDerivative	27378000	usd
CY2021Q4	us-gaap	Convertible Subordinated Debt Current ConvertibleSubordinatedDebtCurrent	9967000	usd
CY2021Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	22236000	usd
CY2022Q3	us-gaap	Liabilities Current LiabilitiesCurrent	33012000	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	36061000	usd
CY2022Q3	us-gaap	Derivative Liabilities DerivativeLiabilities	1038000	usd
CY2022Q3	us-gaap	Long Term Debt LongTermDebt	2918000	usd
CY2022Q3	foxo	Policy Reserves PolicyReserves	18754000	usd
CY2021Q4	foxo	Policy Reserves PolicyReserves	19463000	usd
CY2022Q3	us-gaap	Liabilities Liabilities	55722000	usd
CY2021Q4	us-gaap	Liabilities Liabilities	55524000	usd
CY2022Q3	us-gaap	Common Stock Value CommonStockValue	3000	usd
CY2021Q4	foxo	Undesignated Preferred Stock Par Value UndesignatedPreferredStockParValue	0.00001
CY2021Q4	foxo	Undesignated Preferred Stocksshare Authorized UndesignatedPreferredStocksshareAuthorized	90000000	shares
CY2021Q4	foxo	Nonredeemable Preferred Stock NonredeemablePreferredStock	21854000	usd
CY2022Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	144672000	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	4902000	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-128908000	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-51976000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	15767000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-25220000	usd
CY2022Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	71489000	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	30304000	usd
CY2022Q3	us-gaap	Revenues Revenues	14000	usd
CY2021Q3	us-gaap	Revenues Revenues	31000	usd
CY2021Q3	us-gaap	Operating Expenses OperatingExpenses	4386000	usd
	us-gaap	Operating Expenses OperatingExpenses	19399000	usd
	us-gaap	Revenues Revenues	93000	usd
	us-gaap	Revenues Revenues	93000	usd
CY2022Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	558000	usd
CY2021Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1665000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2160000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4321000	usd
CY2022Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	8269000	usd
CY2021Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2721000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	17239000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	7640000	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	8827000	usd
	us-gaap	Operating Expenses OperatingExpenses	11961000	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-8813000	usd
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-4355000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-19306000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-11868000	usd
CY2022Q3	us-gaap	Fair Value Option Changes In Fair Value Gain Loss1 FairValueOptionChangesInFairValueGainLoss1	-3697000	usd
CY2021Q3	us-gaap	Fair Value Option Changes In Fair Value Gain Loss1 FairValueOptionChangesInFairValueGainLoss1	-22571000	usd
	us-gaap	Fair Value Option Changes In Fair Value Gain Loss1 FairValueOptionChangesInFairValueGainLoss1	-28180000	usd
	us-gaap	Fair Value Option Changes In Fair Value Gain Loss1 FairValueOptionChangesInFairValueGainLoss1	-24890000	usd
CY2022Q3	foxo	Change In Fair Value Of Warrant Liability ChangeInFairValueOfWarrantLiability	-1349000	usd
	foxo	Change In Fair Value Of Warrant Liability ChangeInFairValueOfWarrantLiability	-1349000	usd
CY2022Q3	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-1284000	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-1284000	usd
CY2022Q3	foxo	Change In Fair Value Of Forward Purchase Collateral Derivative ChangeInFairValueOfForwardPurchaseCollateralDerivative	-27378000	usd
	foxo	Change In Fair Value Of Forward Purchase Collateral Derivative ChangeInFairValueOfForwardPurchaseCollateralDerivative	-27378000	usd
CY2022Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-779000	usd
CY2021Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-2000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-883000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-31000	usd
CY2022Q3	us-gaap	Interest Expense InterestExpense	424000	usd
CY2021Q3	us-gaap	Interest Expense InterestExpense	313000	usd
	us-gaap	Interest Expense InterestExpense	1250000	usd
	us-gaap	Interest Expense InterestExpense	825000	usd
CY2022Q3	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-32213000	usd
CY2021Q3	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-22886000	usd
	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-57626000	usd
	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-25746000	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-41026000	usd
CY2021Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-27241000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-76932000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-37614000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-41026000	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-27241000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-76932000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-37614000	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	1190000	usd
CY2021Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-27241000	usd
CY2021Q3	foxo	Lease Contributions LeaseContributions	137000	usd
CY2021Q3	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	45000	usd
CY2021Q3	foxo	Subscriptions Received SubscriptionsReceived	1250000	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	-24619000	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	8720000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-37614000	usd
	foxo	Lease Contributions LeaseContributions	410000	usd
	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	102000	usd
	foxo	Subscriptions Received SubscriptionsReceived	3750000	usd
	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	13000	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	-24619000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	-54002000	usd
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-9531000	usd
CY2022Q3	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	211000	usd
CY2022Q3	foxo	Conversion Of Bridge Loans ConversionOfBridgeLoans	88975000	usd
CY2022Q3	foxo	Conversion Of Existing Class A Common Stock ConversionOfExistingClassACommonStock	1000	usd
CY2022Q3	foxo	Reverse Recapitalization ReverseRecapitalization	19678000	usd
CY2022Q3	foxo	Net Loss After Business Combination NetLossAfterBusinessCombination	-31495000	usd
CY2022Q3	foxo	Equitybased Compensation EquitybasedCompensation	330000	usd
CY2022Q3	foxo	Cantor Commitement Fee CantorCommitementFee	1600000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	15767000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-25220000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-45437000	usd
	foxo	Lease Contributions LeaseContributions	225000	usd
	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	717000	usd
	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	-507000	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	6900000	usd
	foxo	Conversion Of Bridge Loans ConversionOfBridgeLoans	88975000	usd
	foxo	Conversion Of Existing Class A Common Stock ConversionOfExistingClassACommonStock	1000	usd
	foxo	Reverse Recapitalization ReverseRecapitalization	19678000	usd
	foxo	Net Loss After Business Combination NetLossAfterBusinessCombination	-31495000	usd
	foxo	Equitybased Compensation EquitybasedCompensation	330000	usd
	foxo	Cantor Commitement Fee CantorCommitementFee	1600000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	15767000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-76932000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-37614000	usd
	us-gaap	Depreciation Depreciation	159000	usd
	us-gaap	Depreciation Depreciation	71000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1002000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	8000	usd
	foxo	Cantor Commitment Fee CantorCommitmentFee	1600000	usd
	us-gaap	Cost Of Goods And Services Sold Amortization CostOfGoodsAndServicesSoldAmortization	2954000	usd
	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities	28180000	usd
	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities	24890000	usd
	foxo	Increase Decrease In Fair Value Of Forward Purchase Agreement Collateral Derivative IncreaseDecreaseInFairValueOfForwardPurchaseAgreementCollateralDerivative	27378000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-1349000	usd
	foxo	Change In Fair Value Of Forward Purchase Agreement Derivative ChangeInFairValueOfForwardPurchaseAgreementDerivative	1284000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	2309000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6856000	usd
	foxo	Conversion Of Accrued Interest ConversionOfAccruedInterest	593000	usd
	foxo	Contributions In The Form Of Rent Payments ContributionsInTheFormOfRentPayments	225000	usd
	foxo	Contributions In The Form Of Rent Payments ContributionsInTheFormOfRentPayments	410000	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	20000	usd
	foxo	Accretion Of Operating Lease Liabilities AccretionOfOperatingLeaseLiabilities	20000	usd
	foxo	Recognition Of Prepaid Offering Costs Upon Election Of Fair Value Option RecognitionOfPrepaidOfferingCostsUponElectionOfFairValueOption	107000	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	26000	usd
	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	13000	usd
	us-gaap	Increase Decrease In Materials And Supplies IncreaseDecreaseInMaterialsAndSupplies	1762000	usd
	us-gaap	Increase Decrease In Materials And Supplies IncreaseDecreaseInMaterialsAndSupplies	296000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1002000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-55000	usd
	foxo	Cloud Computing Arrangements CloudComputingArrangements	1941000	usd
	foxo	Cloud Computing Arrangements CloudComputingArrangements	1701000	usd
	us-gaap	Increase Decrease In Reinsurance Payables IncreaseDecreaseInReinsurancePayables	709000	usd
	us-gaap	Increase Decrease In Reinsurance Payables IncreaseDecreaseInReinsurancePayables	88000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-489000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	2247000	usd
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	761000	usd
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	197000	usd
	foxo	Increase Decrease In Policy Reserves IncreaseDecreaseInPolicyReserves	709000	usd
	foxo	Increase Decrease In Policy Reserves IncreaseDecreaseInPolicyReserves	88000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-19232000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-11746000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	108000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	73000	usd
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	63000	usd
	us-gaap	Payments For Software PaymentsForSoftware	1622000	usd
	us-gaap	Payments For Software PaymentsForSoftware	9000	usd
	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	50000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1730000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-195000	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	3250000	usd
	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	28000000	usd
	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	7250000	usd
	us-gaap	Payments For Repurchase Of Warrants PaymentsForRepurchaseOfWarrants	507000	usd
	us-gaap	Proceeds From Issuance Of Senior Long Term Debt ProceedsFromIssuanceOfSeniorLongTermDebt	3458000	usd
	foxo	Reverse Recapitalization Proceeds ReverseRecapitalizationProceeds	23226000	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	29135000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	484000	usd
	foxo	Forward Purchase Agreement Collateral Release To Meteora ForwardPurchaseAgreementCollateralReleaseToMeteora	733000	usd
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	539000	usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	1160000	usd
	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	3750000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	24560000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	14250000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	3598000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	8123000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	10454000	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	10432000	usd
	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	54000	usd
	foxo	Shares Subject To Equitable Adjustment SharesSubjectToEquitableAdjustment	9200000	shares
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	88382000	usd
	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	21854000	usd
	foxo	Accrued Internal Use Software AccruedInternalUseSoftware	239000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-41026000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-76932000	usd
	foxo	Retained Earning Appropriated RetainedEarningAppropriated	128908000	usd
	us-gaap	Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities	19232000	usd
CY2022Q3	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	5453000	usd
CY2022Q1	us-gaap	Convertible Debt ConvertibleDebt	28000000	usd
CY2022Q2	us-gaap	Convertible Debt ConvertibleDebt	28000000	usd
CY2021Q4	us-gaap	Prepaid Insurance PrepaidInsurance	63000	usd
CY2022Q3	foxo	Longevity Pipeline LongevityPipeline	512000	usd
CY2021Q4	foxo	Longevity Pipeline LongevityPipeline	75000	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">USE OF ESTIMATES</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of the unaudited consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reported period. Management evaluates these estimates and judgments on an ongoing basis and bases its estimates on experience, current and expected future conditions, third-party evaluations and various other assumptions that management believes are reasonable under the circumstances. It is reasonably possible that actual experience could differ from the estimates and assumptions utilized. All revisions to accounting estimates are recognized in the period in which the estimates are revised. A description of each critical estimate is incorporated within the discussion of the related accounting policies which follow.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2022Q3	foxo	Underwriting Api UnderwritingAPI	839000	usd
CY2021Q4	foxo	Underwriting Api UnderwritingAPI	53000	usd
	foxo	Longevity Api LongevityAPI	657000	usd
CY2022Q3	us-gaap	Intangible Assets Current IntangibleAssetsCurrent	2071000	usd
CY2021Q4	us-gaap	Intangible Assets Current IntangibleAssetsCurrent	191000	usd
	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	63000	usd
	foxo	Percenatge Of Commissions Earned PercenatgeOfCommissionsEarned	0.80	pure
CY2022Q1	foxo	Percentage Of Commission And Fee Revenues PercentageOfCommissionAndFeeRevenues	0.15	pure
	foxo	Percentage Of Commission And Fee Revenues PercentageOfCommissionAndFeeRevenues	0.05	pure
	foxo	Percentage Of Coinsurance Agreement PercentageOfCoinsuranceAgreement	1	pure
CY2022Q3	us-gaap	Prepaid Insurance PrepaidInsurance	63000	usd
CY2022Q3	us-gaap	Other Assets OtherAssets	4709000	usd
CY2021Q4	us-gaap	Other Assets OtherAssets	2745000	usd
	foxo	Senior Notes Percentage SeniorNotesPercentage	0.15	pure
CY2022Q3	foxo	Senior Notes Percentage SeniorNotesPercentage	0.15	pure
CY2022Q3	us-gaap	Investment Owned Balance Principal Amount InvestmentOwnedBalancePrincipalAmount	3458000	usd
CY2022Q3	foxo	Net Proceeds NetProceeds	2918000	usd
CY2022Q3	us-gaap	Exchange Fees ExchangeFees	540000	usd
CY2022Q3	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.15	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Percentage Of Outstanding Stock Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum	1.30	pure
	foxo	Company Loan Description CompanyLoanDescription	The Company loaned Delwinds $387 per month in June 2022, July 2022, and August 2022 prior to Closing of the Business Combination.
CY2022Q3	us-gaap	Related Party Transaction Due From To Related Party RelatedPartyTransactionDueFromToRelatedParty	500000	usd
CY2022Q2	foxo	Agreement Term Period AgreementTermPeriod	P12M
CY2022Q2	foxo	Exchange Fees1 ExchangeFees1	1425000	usd
CY2022Q3	us-gaap	Related Party Tax Expense Due To Affiliates Deferred RelatedPartyTaxExpenseDueToAffiliatesDeferred	2081000	usd
	us-gaap	Related Party Tax Expense Due To Affiliates Deferred RelatedPartyTaxExpenseDueToAffiliatesDeferred	3568000	usd
CY2022Q3	us-gaap	Common Stock No Par Value CommonStockNoParValue	0.0001
CY2022Q3	us-gaap	Excess Stock Shares Authorized ExcessStockSharesAuthorized	510000000	shares
	us-gaap	Preferred Stock Dividends Shares PreferredStockDividendsShares	10000000	shares
CY2022Q3	us-gaap	Capitalization Longterm Debt And Equity CapitalizationLongtermDebtAndEquity	100000000	usd
CY2022Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	10000000	shares
CY2022Q3	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P5Y
	foxo	Warrants Description WarrantsDescription	Once the warrants become exercisable, the Company may redeem the Public Warrants: ●in whole and not in part; ●at a price of $0.01 per warrant; ●upon not less than 30 days’ prior written notice of redemption given after the warrants become exercisable; and ●if, and only if, the reported last sale price of the Company’s Class A Common Stock equals or exceeds $18.00 per share for any 20 trading days within a 30-trading day period commencing once the warrants become exercisable and ending three business days before the Company sends the notice of redemption to the warrant holders.
	us-gaap	Stock Issued During Period Shares Treasury Stock Reissued StockIssuedDuringPeriodSharesTreasuryStockReissued	300000	shares
	foxo	Purchase Agreement PurchaseAgreement	29135000	usd
	foxo	Reset Price Percentage ResetPricePercentage	0.925	pure
CY2022Q3	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	10
CY2022Q3	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.05
	us-gaap	Incremental Common Shares Attributable To Contingently Issuable Shares IncrementalCommonSharesAttributableToContingentlyIssuableShares	9175000	shares
	foxo	Timebased Vesting Description TimebasedVestingDescription	Each restricted share award shall be subject to three service-based vesting conditions: a)Sixty percent (60%) of a participant’s restricted share award will become vested on the third anniversary of the Closing if the participant is still employed by the company on such date (and has been continuously employed by the company from the date of grant through such vesting date). b)An additional twenty percent (20%) of a participant’s restricted share award will become vested on the fourth anniversary of the Closing if the participant is still employed by the company on such date (and has been continuously employed by the company from the date of grant through such vesting date). c)The final twenty percent (20%) of a participant’s restricted share award will become vested on the fifth anniversary of the Closing if the participant is still employed by the company on such date (and has been continuously employed by the company from the date of grant through such vesting date).
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-41026000	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-27241000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-76932000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-37614000	usd
CY2021Q3	us-gaap	Treasury Stock Preferred Shares TreasuryStockPreferredShares	4646698	shares
CY2022Q3	us-gaap	Class Of Warrant Or Right Unissued ClassOfWarrantOrRightUnissued	10378750	shares
CY2022Q3	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	1905853	shares
CY2021Q3	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	1905853	shares
CY2022Q3	foxo	Assumed Option Shares AssumedOptionShares	2965500	shares
CY2021Q3	foxo	Assumed Option Shares AssumedOptionShares	2965500	shares
CY2022Q3	foxo	Total Antidilutive Shares TotalAntidilutiveShares	15250103	shares
CY2021Q3	foxo	Total Antidilutive Shares TotalAntidilutiveShares	24088202	shares
CY2022Q3	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	29700000	usd
CY2021Q4	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	32203000	usd
CY2021	us-gaap	Subordinated Borrowing Interest Rate SubordinatedBorrowingInterestRate	0.52	pure
CY2021Q2	us-gaap	Investments In And Advances To Affiliates At Fair Value InvestmentsInAndAdvancesToAffiliatesAtFairValue	12819000	usd
CY2021Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	22571000	usd
CY2021Q3	us-gaap	Investments In And Advances To Affiliates At Fair Value InvestmentsInAndAdvancesToAffiliatesAtFairValue	35390000	usd
CY2022Q2	us-gaap	Investments In And Advances To Affiliates At Fair Value InvestmentsInAndAdvancesToAffiliatesAtFairValue	84686000	usd
CY2022Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	3697000	usd
CY2022Q3	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	88383000	usd
CY2022Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet	-88383000	usd
CY2022Q3	foxo	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings1 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings1	28662000	usd
CY2022Q3	us-gaap	Investments In And Advances To Affiliates At Fair Value InvestmentsInAndAdvancesToAffiliatesAtFairValue	28662000	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	10500000	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	24890000	usd
CY2021Q3	us-gaap	Investments In And Advances To Affiliates At Fair Value InvestmentsInAndAdvancesToAffiliatesAtFairValue	35390000	usd
CY2021Q4	us-gaap	Investments In And Advances To Affiliates At Fair Value InvestmentsInAndAdvancesToAffiliatesAtFairValue	32203000	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	28000000	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	28180000	usd
CY2022Q3	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	88383000	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet	-88383000	usd
	foxo	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings1 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings1	28662000	usd
CY2022Q3	us-gaap	Investments In And Advances To Affiliates At Fair Value InvestmentsInAndAdvancesToAffiliatesAtFairValue	28662000	usd
CY2021Q3	us-gaap	Cost Of Revenue CostOfRevenue	31000	usd
CY2022Q3	us-gaap	Related Party Transaction Purchases From Related Party RelatedPartyTransactionPurchasesFromRelatedParty	1656000	usd
CY2021Q3	us-gaap	Related Party Transaction Purchases From Related Party RelatedPartyTransactionPurchasesFromRelatedParty	2463000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	93000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	93000	usd
	us-gaap	Related Party Transaction Purchases From Related Party RelatedPartyTransactionPurchasesFromRelatedParty	5022000	usd
	us-gaap	Related Party Transaction Purchases From Related Party RelatedPartyTransactionPurchasesFromRelatedParty	5935000	usd
CY2022Q3	us-gaap	Cost Of Revenue CostOfRevenue	14000	usd
CY2022Q3	foxo	Interest Expense Earnings InterestExpenseEarnings	-424000	usd
CY2021Q3	foxo	Interest Expense Earnings InterestExpenseEarnings	-313000	usd
	foxo	Interest Expense Earnings InterestExpenseEarnings	-1250000	usd
	foxo	Interest Expense Earnings InterestExpenseEarnings	-825000	usd
CY2022Q3	us-gaap	Revenues Revenues	14000	usd
CY2021Q3	us-gaap	Revenues Revenues	31000	usd
CY2022Q3	us-gaap	Distributed Earnings DistributedEarnings	41026000	usd
CY2021Q3	us-gaap	Distributed Earnings DistributedEarnings	27241000	usd
	us-gaap	Revenues Revenues	93000	usd
	us-gaap	Revenues Revenues	93000	usd
	us-gaap	Distributed Earnings DistributedEarnings	76932000	usd
	us-gaap	Distributed Earnings DistributedEarnings	37614000	usd
CY2022Q3	foxo	Consulting Agreement Expense ConsultingAgreementExpense	3866000	usd
CY2021Q3	foxo	Consulting Agreement Expense ConsultingAgreementExpense	42000	usd
CY2022Q3	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	74000	usd
CY2021Q3	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	25000	usd
	foxo	Consulting Agreement Expense ConsultingAgreementExpense	5556000	usd
	foxo	Consulting Agreement Expense ConsultingAgreementExpense	8000	usd
	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	159000	usd
	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	71000	usd
CY2022Q3	foxo	Changes In Fair Value Of Convertible Debentures Warrant Liability And Forward Purchase Derivative ChangesInFairValueOfConvertibleDebenturesWarrantLiabilityAndForwardPurchaseDerivative	31010000	usd
CY2021Q3	foxo	Changes In Fair Value Of Convertible Debentures Warrant Liability And Forward Purchase Derivative ChangesInFairValueOfConvertibleDebenturesWarrantLiabilityAndForwardPurchaseDerivative	22571000	usd
CY2022Q3	foxo	Excess Stock Shares Issued1 ExcessStockSharesIssued1		shares
	foxo	Changes In Fair Value Of Convertible Debentures Warrant Liability And Forward Purchase Derivative ChangesInFairValueOfConvertibleDebenturesWarrantLiabilityAndForwardPurchaseDerivative	55493000	usd
	foxo	Changes In Fair Value Of Convertible Debentures Warrant Liability And Forward Purchase Derivative ChangesInFairValueOfConvertibleDebenturesWarrantLiabilityAndForwardPurchaseDerivative	24890000	usd
CY2021Q3	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss		usd
	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss		usd
	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss		usd
	foxo	Longevity Api LongevityAPI		usd
	foxo	Purchase Units PurchaseUnits	10000	shares
	us-gaap	Derivative Term Of Contract DerivativeTermOfContract	P3Y
CY2022Q3	us-gaap	Purchase Obligation PurchaseObligation	788	usd
CY2022Q3	foxo	Purchase Units PurchaseUnits	10000	shares
CY2022Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	849	usd
	foxo	Enrollment Description EnrollmentDescription	(i) 20% upon the enrollment of the first patient, (ii) 20% upon the enrollment of the final patient and (iii) 10% upon lab receipt of shipments for all initially planned assays. Costs associated with the clinical trial agreement are being recorded as research and development expenses in the consolidated statements of operations.
	foxo	Agreement Amount AgreementAmount	200	usd
CY2022Q3	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	40	usd
CY2021Q3	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	38	usd
	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	119	usd
	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	101	usd
	foxo	Minimum Of Participants MinimumOfParticipants	2500	shares
	us-gaap	Insurance Recoveries InsuranceRecoveries	200	usd
CY2021Q4	foxo	Forward Purchase Collateral ForwardPurchaseCollateral		usd
CY2021Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent		usd
CY2021Q4	us-gaap	Deposit Liability Current DepositLiabilityCurrent		usd
CY2021Q4	foxo	Parallel Run Advance ParallelRunAdvance		usd
CY2021Q4	foxo	Forward Purchase Put Derivative ForwardPurchasePutDerivative		usd
CY2021Q4	foxo	Forward Purchase Collateral Derivative ForwardPurchaseCollateralDerivative		usd
CY2022Q3	us-gaap	Convertible Subordinated Debt Current ConvertibleSubordinatedDebtCurrent		usd
CY2022Q3	us-gaap	Convertible Debt Current ConvertibleDebtCurrent		usd
CY2021Q4	us-gaap	Derivative Liabilities DerivativeLiabilities		usd
CY2021Q4	us-gaap	Long Term Debt LongTermDebt		usd
CY2022Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q3	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue		usd
CY2022Q3	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss		usd
CY2022Q3	us-gaap	Excess Stock Shares Outstanding ExcessStockSharesOutstanding		shares
CY2022Q3	us-gaap	Treasury Stock Preferred Shares TreasuryStockPreferredShares		shares
CY2021Q3	us-gaap	Class Of Warrant Or Right Unissued ClassOfWarrantOrRightUnissued		shares
CY2020Q4	us-gaap	Investments In And Advances To Affiliates At Fair Value InvestmentsInAndAdvancesToAffiliatesAtFairValue		usd
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity Central Index Key EntityCentralIndexKey	0001812360

Files In Submission

Name	View Source	Status
0001213900-22-074296-index-headers.html	Edgar Link	pending
0001213900-22-074296-index.html	Edgar Link	pending
0001213900-22-074296.txt	Edgar Link	pending
0001213900-22-074296-xbrl.zip	Edgar Link	pending
ex10-12_001.jpg	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
ex10-15_001.jpg	Edgar Link	pending
f10q0922ex10-10_foxotech.htm	Edgar Link	pending
f10q0922ex10-11_foxotech.htm	Edgar Link	pending
f10q0922ex10-12_foxotech.htm	Edgar Link	pending
f10q0922ex10-13_foxotech.htm	Edgar Link	pending
f10q0922ex10-14_foxotech.htm	Edgar Link	pending
f10q0922ex10-15_foxotech.htm	Edgar Link	pending
f10q0922ex31-1_foxotech.htm	Edgar Link	pending
f10q0922ex31-2_foxotech.htm	Edgar Link	pending
f10q0922ex32-1_foxotech.htm	Edgar Link	pending
f10q0922ex32-2_foxotech.htm	Edgar Link	pending
f10q0922_foxotech.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
foxo-20220930.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
foxo-20220930_cal.xml	Edgar Link	unprocessable
foxo-20220930_def.xml	Edgar Link	unprocessable
foxo-20220930_lab.xml	Edgar Link	unprocessable
foxo-20220930_pre.xml	Edgar Link	unprocessable
f10q0922_foxotech_htm.xml	Edgar Link	completed
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$FOXO
FOXO TECHNOLOGIES INC. Stock $foxo

2022 Q4 Form 10-Q Financial Statement

#000121390022074296 Filed on November 21, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$FOXO FOXO TECHNOLOGIES INC. Stock $foxo

2022 Q4 Form 10-Q Financial Statement

#000121390022074296 Filed on November 21, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$FOXO
FOXO TECHNOLOGIES INC. Stock $foxo